Procalcitonin (PCT), a marker that exhibits greater specificity than other proinflammatory markers in
identifying patients with sepsis, is a novel assay that may
also be useful in the management of patients with sepsis and other bacterial
infections. During this 60-minute
webinar, Dr. James Peele review what?s currently known about this test, how
clinicians are using it in clinical practice, and how it might be used in the
future (This is a recorded version of an AACC live webinar
that was held September 24, 2015).